Back to Search
Start Over
JAMP Launches Novel Competition Complaint Alleging Janssen Abused Its Dominance Over Stelara (Ustekinumab)
- Source :
- Mondaq Business Briefing. August 29, 2024
- Publication Year :
- 2024
-
Abstract
- On July 26, 2024, JAMP Pharma Corporation ('JAMP') - a Canadian generic/biosimilar pharmaceutical company - applied for leave to the Competition Tribunal (the 'Tribunal') to bring an application under the [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Mondaq Business Briefing
- Publication Type :
- News
- Accession number :
- edsgcl.806503246